Inclusion Body Myositis Treatment With Celution Processed Adipose Derived Regenerative Cells

NAActive, not recruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 10, 2022

Primary Completion Date

September 29, 2025

Study Completion Date

September 29, 2025

Conditions
Inclusion Body Myositis
Interventions
DEVICE

Adipose Derived Regenerative Cells

"The Cytori Celution technology is an automated version of the process and techniques used in the research laboratory to isolate regenerative cells from adipose tissue. The Cytori Celution System uses a proteolytic enzyme blend (Celase) to disrupt the adipose tissue matrix and release the entrapped adipose derived regenerative cells (ADRCs), also referred to in the literature as stromal vascular fraction cells. Once digested, the digestate is separated into fractions (buoyant adipocytes (fat cells) and pelleted ADRCs) by centrifugation. The non-buoyant cell pellet (ADRCs) is then washed and centrifuged through several cycles to remove residual enzyme reagent and cellular debris. Although the Cytori Celution technology replicates known laboratory techniques, it offers significant improvements to the manual laboratory technique by controlling the processing in a closed system that has been validated for safety, performance, and reproducibility."

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
lead

University of Kansas Medical Center

OTHER